GB2260702B - Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X - Google Patents

Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X

Info

Publication number
GB2260702B
GB2260702B GB9222012A GB9222012A GB2260702B GB 2260702 B GB2260702 B GB 2260702B GB 9222012 A GB9222012 A GB 9222012A GB 9222012 A GB9222012 A GB 9222012A GB 2260702 B GB2260702 B GB 2260702B
Authority
GB
United Kingdom
Prior art keywords
haemophilia
factor
treatment
subcutaneous injection
improvements relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9222012A
Other versions
GB2260702A (en
GB9222012D0 (en
Inventor
George Gow Brownlee
Ann Justine Gerrard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Publication of GB9222012D0 publication Critical patent/GB9222012D0/en
Publication of GB2260702A publication Critical patent/GB2260702A/en
Application granted granted Critical
Publication of GB2260702B publication Critical patent/GB2260702B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
GB9222012A 1991-10-24 1992-10-20 Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X Expired - Fee Related GB2260702B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919122609A GB9122609D0 (en) 1991-10-24 1991-10-24 Improvements relating to the treatment of haemophilia

Publications (3)

Publication Number Publication Date
GB9222012D0 GB9222012D0 (en) 1992-12-02
GB2260702A GB2260702A (en) 1993-04-28
GB2260702B true GB2260702B (en) 1995-09-20

Family

ID=10703480

Family Applications (2)

Application Number Title Priority Date Filing Date
GB919122609A Pending GB9122609D0 (en) 1991-10-24 1991-10-24 Improvements relating to the treatment of haemophilia
GB9222012A Expired - Fee Related GB2260702B (en) 1991-10-24 1992-10-20 Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB919122609A Pending GB9122609D0 (en) 1991-10-24 1991-10-24 Improvements relating to the treatment of haemophilia

Country Status (5)

Country Link
EP (1) EP0609293A1 (en)
JP (1) JPH07502989A (en)
AU (1) AU2772092A (en)
GB (2) GB9122609D0 (en)
WO (1) WO1993007890A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504074C2 (en) † 1993-07-05 1996-11-04 Pharmacia Ab Protein preparation for subcutaneous, intramuscular or intradermal administration
IL113010A (en) * 1994-03-31 1999-10-28 Pharmacia & Upjohn Ab Pharmaceutical formulation comprising factor viii with an activity of at least 500iu/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
US7786070B2 (en) 1997-09-10 2010-08-31 Novo Nordisk Healthcare A/G Subcutaneous administration of coagulation factor VII
JP5090605B2 (en) 2000-05-03 2012-12-05 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Subcutaneous administration of coagulation factor VII
US20120148557A1 (en) * 2009-08-20 2012-06-14 Ulrich Kronthaler Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991010439A1 (en) * 1990-01-19 1991-07-25 Octapharma Ag Stable injectible solutions for factor viii and factor ix

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0430930B1 (en) * 1985-03-15 1993-09-01 Btg International Limited Factor ix protein

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991010439A1 (en) * 1990-01-19 1991-07-25 Octapharma Ag Stable injectible solutions for factor viii and factor ix

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Br.J.Haematol. 81(4) pages 610-3 August 1992 *
Dictionnaire Vidal (1990) page 653 "Facteur IX humain haute purete" *
Martindale, The Extra Pharmacopoeia, 29th Edition (1989) page 817 entry 1227-a *

Also Published As

Publication number Publication date
WO1993007890A1 (en) 1993-04-29
JPH07502989A (en) 1995-03-30
EP0609293A1 (en) 1994-08-10
GB9122609D0 (en) 1991-12-04
GB2260702A (en) 1993-04-28
GB9222012D0 (en) 1992-12-02
AU2772092A (en) 1993-05-21

Similar Documents

Publication Publication Date Title
DE69030591D1 (en) Subcutaneous injection
GB9016789D0 (en) Medicament administering devices
IL102941A0 (en) Injection syringe
EP0356810A3 (en) Self-sheathing hypodermic needle
HUT59017A (en) Injection syringe
IL101360A0 (en) Injection syringe
DE69331626T2 (en) Multi-purpose infusion cannula
GB9020749D0 (en) Improved single-use syringe
GB8911487D0 (en) Therapeutic stockings
ZA938064B (en) Catheter with clear needle shaft
HU9302192D0 (en) Injection needle
ZA899066B (en) Fabric treatment composition
GB2260702B (en) Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X
GB2248021B (en) Vein needle set
EP0253990A3 (en) Intravenous cannula
NO960545D0 (en) Treatment of adverse effects associated with the administration of extracellular hemoglobin
GB9101525D0 (en) Improvements in or relating to the protection of needle points
GB9000761D0 (en) Syringe needle with safety feature
ZA899065B (en) Fabric treatment composition
GB2241893B (en) Hypodermic syringe
IE860956L (en) Administering insulin
PL283596A1 (en) Disposable injection needle
ZA907531B (en) Injection syringe
IE861321L (en) Medicament injection with electrical blood absorbing¹stimulation
GB9210668D0 (en) Improvements relating to hypodermic syringes

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19961020